{"DataElement":{"publicId":"3288124","version":"1","preferredName":"Tumor Tissue Disease Description Type","preferredDefinition":"Text that describes the kind of disease present in the tumor specimen as related to a specific timepoint.","longName":"3288120v1.0:3288102v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3288120","version":"1","preferredName":"Tumor Tissue Disease Description","preferredDefinition":"A tissue sample, or entire tumor that is removed for microscopic examination._Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._Description; a statement that represents something in words.","longName":"3288077v1.0:3288118v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3288077","version":"1","preferredName":"Tumor Tissue","preferredDefinition":"A tissue sample, or entire tumor that is removed for microscopic examination.","longName":"C18009","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE66036F-0ED7-6497-E040-BB89AD435669","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"3288118","version":"1","preferredName":"Disease or Disorder Description","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.:Description; a statement that represents something in words.","longName":"C2991:C25365","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Description","conceptCode":"C25365","definition":"A written or verbal account, representation, statement, or explanation of something.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6709A9-47B3-488E-E040-BB89AD437FF6","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6709A9-47C4-488E-E040-BB89AD437FF6","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3288102","version":"1","preferredName":"Tumor Tissue Type","preferredDefinition":"A tissue sample, or entire tumor that is removed for microscopic examination._Type; a subdivision of a particular kind of thing.","longName":"3288102v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"100","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Tumor specimen from de novo untreated malignancy of the bladder","valueDescription":"Tumor Tissue From de novo Untreated Bladder Carcinoma","ValueMeaning":{"publicId":"3288103","version":"1","preferredName":"Tumor Tissue From de novo Untreated Bladder Carcinoma","longName":"3288103","preferredDefinition":"A tissue sample, or entire tumor that is removed for microscopic examination.: Used to indicate a specified place or time as a starting point.: (dih NO-vo) In cancer, the first occurrence of cancer in the body.: An operation in which a term denies or inverts the meaning of another term or construction.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.: A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"5"},{"longName":"From","conceptCode":"C25516","definition":"Used to indicate a specified place or time as a starting point; used to indicate a source, cause, agent, or instrument.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"de novo","conceptCode":"C28354","definition":"Anew, afresh, or over again from the beginning.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Bladder Carcinoma","conceptCode":"C4912","definition":"A carcinoma arising from the bladder epithelium.  Approximately 90% of the bladder carcinomas are transitional cell carcinomas.  The remainder are squamous cell carcinomas, adenocarcinomas and small cell neuroendocrine carcinomas.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE66AFF8-0826-789A-E040-BB89AD437932","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE66AFF8-083F-789A-E040-BB89AD437932","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"Recurrent","valueDescription":"Recurrent Tumor Tissue","ValueMeaning":{"publicId":"3288104","version":"1","preferredName":"Recurrent Tumor Tissue","longName":"3288104","preferredDefinition":"occurring again.: A tissue sample, or entire tumor that is removed for microscopic examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recurrent","conceptCode":"C14173","definition":"Occurring again.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE66AFF8-084C-789A-E040-BB89AD437932","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE66AFF8-0865-789A-E040-BB89AD437932","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"Metastatic","valueDescription":"Metastatic Tumor Tissue","ValueMeaning":{"publicId":"3288105","version":"1","preferredName":"Metastatic Tumor Tissue","longName":"3288105","preferredDefinition":"(MET-uh-STAT-ik) Having to do with metastasis, which is the spread of cancer from one part of the body to another.: A tissue sample, or entire tumor that is removed for microscopic examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Metastatic","conceptCode":"C14174","definition":"A term referring to the clinical or pathologic observation of a tumor extension from its original site of growth to another anatomic site.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE66AFF8-0872-789A-E040-BB89AD437932","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE66AFF8-088B-789A-E040-BB89AD437932","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"Primary","valueDescription":"Primary Untreated Malignant Tumor Tissue","ValueMeaning":{"publicId":"3288106","version":"1","preferredName":"Primary Untreated Malignant Tumor Tissue","longName":"3288106","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary): An operation in which a term denies or inverts the meaning of another term or construction.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.: (ma-LIG-nant) Cancerous; a growth with a tendency to invade and destroy nearby tissue and spread to other parts of the body.: A tissue sample, or entire tumor that is removed for microscopic examination.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Malignant","conceptCode":"C14143","definition":"Refers to abnormal cell activity manifested by decreased control over growth and function, causing tumor growth or spread into surrounding tissue and adverse effects to the host.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE66AFF8-0898-789A-E040-BB89AD437932","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"AE66AFF8-08B1-789A-E040-BB89AD437932","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","deletedIndicator":"No"},{"value":"Additional Primary","valueDescription":"Additional Primary Neoplasm","ValueMeaning":{"publicId":"5085077","version":"1","preferredName":"Additional Primary Neoplasm","longName":"5085077","preferredDefinition":"Added; extra; further.: A tumor at the original site of origin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Primary Neoplasm","conceptCode":"C8509","definition":"A tumor at the original site of origin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"26F6C099-3FD9-70D0-E050-BB89AD436FF9","latestVersionIndicator":"Yes","beginDate":"2015-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"26F6C099-3FF2-70D0-E050-BB89AD436FF9","beginDate":"2015-12-15","endDate":null,"createdBy":"COOPERM","dateCreated":"2015-12-15","modifiedBy":"ONEDATA","dateModified":"2015-12-15","deletedIndicator":"No"},{"value":"NOS","valueDescription":"Not Otherwise Specified","ValueMeaning":{"publicId":"2853071","version":"1","preferredName":"Not Otherwise Specified","longName":"2853071","preferredDefinition":"Not characterized in any other way.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Otherwise Specified","conceptCode":"C19594","definition":"Not characterized in any other way.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"657898D4-807A-7305-E040-BB89AD437E47","latestVersionIndicator":"Yes","beginDate":"2009-03-19","endDate":null,"createdBy":"CURTIST","dateCreated":"2009-03-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3A5FB9C7-F9C3-BEE6-E050-BB89AD430AE0","beginDate":"2016-08-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-18","modifiedBy":"ONEDATA","dateModified":"2016-08-18","deletedIndicator":"No"},{"value":"Xenograft","valueDescription":"Xenograft","ValueMeaning":{"publicId":"5424196","version":"1","preferredName":"Xenograft","longName":"5424196","preferredDefinition":"The transfer of cells, tissues, or organs from a donor into a recipient of another species.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Xenograft","conceptCode":"C12932","definition":"Cells, tissues, or organs from a donor that are transplanted into a recipient of another species.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3A5FB9C7-F9CE-BEE6-E050-BB89AD430AE0","latestVersionIndicator":"Yes","beginDate":"2016-08-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-18","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3A5FB9C7-F9E7-BEE6-E050-BB89AD430AE0","beginDate":"2016-08-18","endDate":null,"createdBy":"COOPERM","dateCreated":"2016-08-18","modifiedBy":"ONEDATA","dateModified":"2016-08-18","deletedIndicator":"No"},{"value":"Premalignant","valueDescription":"Premalignant","ValueMeaning":{"publicId":"6396947","version":"1","preferredName":"Premalignant","longName":"6396947","preferredDefinition":"Descriptive of a condition that may or is likely to become cancerous.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Premalignant","conceptCode":"C25624","definition":"Descriptive of a condition that may or is likely to become cancerous.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7359E851-0348-6589-E053-F662850AC0FD","latestVersionIndicator":"Yes","beginDate":"2018-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2018-08-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7359E851-0361-6589-E053-F662850AC0FD","beginDate":"2018-08-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-08-14","modifiedBy":"ONEDATA","dateModified":"2018-08-14","deletedIndicator":"No"},{"value":"Local recurrence","valueDescription":"Locally Recurrent Malignant Neoplasm","ValueMeaning":{"publicId":"6771068","version":"1","preferredName":"Locally Recurrent Malignant Neoplasm","longName":"6771068","preferredDefinition":"The reemergence of a malignant neoplasm after a period of remission at the site of the original tumor or adjacent to it.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Locally Recurrent Malignant Neoplasm","conceptCode":"C94796","definition":"The reemergence of a malignant neoplasm after a period of remission at the site of the original tumor or adjacent to it.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8A1AE139-F8DD-798E-E053-F662850A3BB5","latestVersionIndicator":"Yes","beginDate":"2019-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8A1AE139-F8F6-798E-E053-F662850A3BB5","beginDate":"2019-05-30","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-05-30","modifiedBy":"ONEDATA","dateModified":"2019-05-30","deletedIndicator":"No"},{"value":"Not reported","valueDescription":"Not Reported","ValueMeaning":{"publicId":"2572231","version":"1","preferredName":"Not Reported","longName":"2572231","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E734-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-11-16","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8CAF241-98F2-3E8F-E053-4EBD850ACB07","beginDate":"2021-01-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-13","modifiedBy":"ONEDATA","dateModified":"2021-01-13","deletedIndicator":"No"},{"value":"Not applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8CAF241-98DE-3E8F-E053-4EBD850ACB07","beginDate":"2021-01-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-13","modifiedBy":"ONEDATA","dateModified":"2021-01-13","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B8CAF241-98E8-3E8F-E053-4EBD850ACB07","beginDate":"2021-01-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-01-13","modifiedBy":"ONEDATA","dateModified":"2021-01-13","deletedIndicator":"No"},{"value":"Atypia or hyperplasia","valueDescription":"Atypia Hyperplasia","ValueMeaning":{"publicId":"7626257","version":"1","preferredName":"Atypia Hyperplasia","longName":"7626257","preferredDefinition":"The condition of being irregular or not conforming to type.: An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypia","conceptCode":"C9478","definition":"The condition of being irregular or not conforming to type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Hyperplasia","conceptCode":"C3113","definition":"An abnormal increase in the number of cells in an organ or a tissue with consequent enlargement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF284DDC-A628-7879-E053-4EBD850A9D7D","latestVersionIndicator":"Yes","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A641-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"},{"value":"Normal adjacent","valueDescription":"Tissue Adjacent","ValueMeaning":{"publicId":"7626258","version":"1","preferredName":"Tissue Adjacent","longName":"7626258","preferredDefinition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.: Next to or adjoining.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Adjacent","conceptCode":"C25408","definition":"Next to or adjoining.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF284DDC-A64E-7879-E053-4EBD850A9D7D","latestVersionIndicator":"Yes","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A667-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"},{"value":"Normal distant","valueDescription":"Tissue Distant","ValueMeaning":{"publicId":"7626259","version":"1","preferredName":"Tissue Distant","longName":"7626259","preferredDefinition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.: Far apart in space from a point of origin on the body.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Distant","conceptCode":"C25321","definition":"Far apart in space from a point of origin on the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF284DDC-A674-7879-E053-4EBD850A9D7D","latestVersionIndicator":"Yes","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A68D-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Tissue","ValueMeaning":{"publicId":"2567371","version":"1","preferredName":"Tissue","longName":"2567371","preferredDefinition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D438-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-18","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-18","modifiedBy":"COOPERM","dateModified":"2020-11-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A6A1-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"},{"value":"Tumor post-adjuvant therapy     ","valueDescription":"Tumor Tissue Post-Adjuvant Therapy","ValueMeaning":{"publicId":"7626261","version":"1","preferredName":"Tumor Tissue Post-Adjuvant Therapy","longName":"7626261","preferredDefinition":"A tumor sample, or entire tumor that is removed for microscopic examination.: Therapy administered after to the initial therapy.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Post-Adjuvant Therapy","conceptCode":"C158707","definition":"Therapy administered after to the initial therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF284DDC-A6AF-7879-E053-4EBD850A9D7D","latestVersionIndicator":"Yes","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A6C8-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"},{"value":"Tumor post-neoadjuvant therapy    ","valueDescription":"Tumor Tissue Post Neoadjuvant Therapy Sample","ValueMeaning":{"publicId":"7626263","version":"1","preferredName":"Tumor Tissue Post Neoadjuvant Therapy Sample","longName":"7626263","preferredDefinition":"A tumor sample, or entire tumor that is removed for microscopic examination.: A biospecimen derived from a subject after treatment with a neoadjuvant therapeutic.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Post Neoadjuvant Therapy Sample","conceptCode":"C156444","definition":"A biospecimen derived from a subject after treatment with a neoadjuvant therapeutic.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF284DDC-A6D6-7879-E053-4EBD850A9D7D","latestVersionIndicator":"Yes","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A6EF-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"},{"value":"Tumor post-therapy","valueDescription":"Tumor Tissue Post-Therapy","ValueMeaning":{"publicId":"7626264","version":"1","preferredName":"Tumor Tissue Post-Therapy","longName":"7626264","preferredDefinition":"A tumor sample, or entire tumor that is removed for microscopic examination.: Occurring after a therapeutic procedure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Post-Therapy","conceptCode":"C54735","definition":"Occurring after a therapeutic procedure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BF284DDC-A6FC-7879-E053-4EBD850A9D7D","latestVersionIndicator":"Yes","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A715-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"},{"value":"Tissue","valueDescription":"Normal Tissue","ValueMeaning":{"publicId":"3081868","version":"1","preferredName":"Normal Tissue","longName":"3081868","preferredDefinition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tissue","conceptCode":"C12801","definition":"An anatomical structure consisting of similarly specialized cells and intercellular matrix, aggregated according to genetically determined spatial relationships, performing a specific function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85BDFA4B-65FC-4570-E040-BB89AD4319EC","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"REEVESD","dateCreated":"2010-05-04","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BF284DDC-A71F-7879-E053-4EBD850A9D7D","beginDate":"2021-04-04","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2021-04-04","modifiedBy":"ONEDATA","dateModified":"2021-04-04","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008547","version":"1","preferredName":"Specimen Characteristics","preferredDefinition":"attributes of a patient's laboratory sample, including the source, condition, and fixative.","longName":"SPEC_CHAR","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22908C4-638F-4A74-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3288101","version":"1","preferredName":"Tumor Tissue Type","preferredDefinition":"A tissue sample, or entire tumor that is removed for microscopic examination.:Type; a subdivision of a particular kind of thing.","longName":"C18009:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Tissue Sample","conceptCode":"C18009","definition":"Tissue sample that contains an abnormal cellular infiltrate forming a solid mass. The abnormal cellular component can be benign or malignant. Tumor samples are obtained for microscopic examination and/or molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE66AFF8-07F8-789A-E040-BB89AD437932","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"ONEDATA","dateModified":"2011-10-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE66AFF8-0809-789A-E040-BB89AD437932","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"KNABLEJ","dateModified":"2021-04-04","changeDescription":"4/4/21 jk HTAN PVs for Tumor/Normal, Atypia added.  1/13/21 jk added 3 PVs for MCL reuse.  --- Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2812367","version":"1","longName":"caBIG","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"2183535","version":"1","longName":"Clinical Trial Mgmt Systems","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2812625","version":"1","longName":"CTMS C3D Adopter Sites","context":"NCIP"},{"publicId":"2812571","version":"1","longName":"Lombardi Cancer Center","context":"NCIP"}]},{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787515","version":"1","longName":"PAAD","context":"NCIP"},{"publicId":"3787505","version":"1","longName":"HNSC","context":"NCIP"},{"publicId":"3787508","version":"1","longName":"KIRP","context":"NCIP"},{"publicId":"3787513","version":"1","longName":"LUSC","context":"NCIP"},{"publicId":"3787516","version":"1","longName":"PRAD","context":"NCIP"},{"publicId":"3787502","version":"1","longName":"CESC","context":"NCIP"},{"publicId":"3787503","version":"1","longName":"COAD","context":"NCIP"},{"publicId":"3787506","version":"1","longName":"KICH","context":"NCIP"},{"publicId":"3787507","version":"1","longName":"KIRC","context":"NCIP"},{"publicId":"3787499","version":"1","longName":"BLCA","context":"NCIP"},{"publicId":"3787500","version":"1","longName":"BRCA","context":"NCIP"},{"publicId":"3787510","version":"1","longName":"LGG","context":"NCIP"},{"publicId":"3787509","version":"1","longName":"LAML","context":"NCIP"},{"publicId":"3787511","version":"1","longName":"LIHC","context":"NCIP"},{"publicId":"3787519","version":"1","longName":"SKCM","context":"NCIP"},{"publicId":"3787512","version":"1","longName":"LUAD","context":"NCIP"},{"publicId":"3787517","version":"1","longName":"READ","context":"NCIP"},{"publicId":"3787518","version":"1","longName":"SARC","context":"NCIP"},{"publicId":"3787520","version":"1","longName":"STAD","context":"NCIP"},{"publicId":"3787522","version":"1","longName":"UCEC","context":"NCIP"},{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"}]},{"publicId":"5428034","version":"1","longName":"Clinical","context":"GDC","ClassificationSchemeItems":[{"publicId":"10000695","version":"1","longName":"Diagnosis","context":"GDC"}]},{"publicId":"5855659","version":"1","longName":"Biospecimen","context":"MCL","ClassificationSchemeItems":[{"publicId":"7018914","version":"1","longName":"Biospecimen CDEs","context":"MCL"}]},{"publicId":"7576399","version":"1","longName":"HTAN Biospecimen CDEs","context":"HTAN","ClassificationSchemeItems":[{"publicId":"7577840","version":"1","longName":"Tier 2 Assay-specific","context":"HTAN"}]},{"publicId":"7639423","version":"1","longName":"SRRS-Standardized Repository of Reference Specimens","context":"HTAN","ClassificationSchemeItems":[{"publicId":"7639046","version":"1","longName":"SRRS Biospecimen","context":"HTAN"}]},{"publicId":"8064110","version":"1","longName":"CDS (Cancer Data Service)","context":"CRDC","ClassificationSchemeItems":[{"publicId":"14470388","version":"1","longName":"Imaging","context":"CRDC"}]}],"AlternateNames":[{"name":"tumor_type","type":"TCGA_XML_Name","context":"NCIP"},{"name":"3288120v1.0:3288102v1.0","type":"USED_BY","context":"AECC"},{"name":"GDC","type":"USED_BY","context":"GDC"},{"name":"OCG","type":"USED_BY","context":"OCG"},{"name":"tumor_type","type":"HCMI Name","context":"OCG"},{"name":"TISSUE_TYPE","type":"HTAN Alt Name","context":"HTAN"},{"name":"HTAN","type":"USED_BY","context":"HTAN"},{"name":"MCL","type":"USED_BY","context":"MCL"},{"name":"tumor_tissue_type","type":"MCL Alt Name","context":"MCL"},{"name":"tumor_tissue_type","type":"CDS Alt Name","context":"CRDC"}],"ReferenceDocuments":[{"name":"TCGA Additional Information","type":"COMMENT","description":"(primary untreated malignant biospecimen)","url":null,"context":"NCIP"},{"name":"Tumor Type","type":"Preferred Question Text","description":"Tumor Type","url":null,"context":"NCIP"},{"name":"Type of Tumor Tissue Disease Description:","type":"Alternate Question Text","description":"Type of Tumor Tissue Disease Description:","url":null,"context":"NCIP"},{"name":"Tumor Category","type":"Alternate Question Text","description":"Tumor Category","url":null,"context":"NCIP"},{"name":"GDC Question Text","type":"Alternate Question Text","description":"Tumor Descriptor","url":null,"context":"GDC"},{"name":"HCMI Question Text","type":"Alternate Question Text","description":"Tumor tissue type","url":null,"context":"OCG"},{"name":"HTAN Term","type":"Alternate Question Text","description":"Tissue Type","url":null,"context":"HTAN"},{"name":"MCL-Biospecimen","type":"Alternate Question Text","description":"Tumor tissue type","url":null,"context":"MCL"},{"name":"MCL-Template Name","type":"Data Collection Template","description":"biospecimen_cdedictionary_v0-2_2021_12_13-metrics.xlsx","url":"https://mcl.nci.nih.gov/resources/standards/mcl-cdes","context":"MCL"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"AE66AFF8-09B6-789A-E040-BB89AD437932","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"FINCHAMB","dateModified":"2024-02-06","changeDescription":"12/16/21 mr Added alt name, AQT, alt def, ref doc, MCL biospecimen CSI per DCT.   4/21/21 jk upd HTAN/SRRS CSIs, added \"Qualified\" RS for HTAN reuse. 4/13/21 jk added HTAN CSI.  4/4/21 jk added to HTAN tier 1; add alt name.  --- Released per approval by T.Lichtenberg. mc 10/5/11","administrativeNotes":"2/6/24 Added CDS Alt name, def and CSI. BF;","unresolvedIssues":null,"deletedIndicator":"No"}}